Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
HRMY
HRMY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
HRMY News
Wall Street Analysts Adjust Ratings
Feb 25 2026
Benzinga
Harmony Biosciences Q4 2025 Earnings Highlights
Feb 24 2026
seekingalpha
Harmony Biosciences Q4 Earnings Analysis
Feb 24 2026
seekingalpha
Harmony Biosciences Reports $868.5 Million Revenue for 2025, Guidance for 2026 Exceeds $1 Billion
Feb 24 2026
Newsfilter
Harmony Biosciences Downgraded, Shares Drop 10%
Feb 23 2026
seekingalpha
Harmony Biosciences to Announce Q4 Earnings on February 24
Feb 23 2026
seekingalpha
Harmony Biosciences Receives FDA Approval for Wakix Label Expansion
Feb 17 2026
seekingalpha
Harmony Receives FDA Approval for Wakix in Pediatric Narcolepsy
Feb 17 2026
stocktwits
Harmony Biosciences CFO Executes Stock Sale
Feb 01 2026
Fool
Harmony Biosciences CFO Sells Shares
Feb 01 2026
NASDAQ.COM
Harmony Biosciences CFO Fully Exits Equity Ownership
Feb 01 2026
Fool
Harmony Biosciences CFO Fully Exits Equity Ownership
Feb 01 2026
Yahoo Finance
Harmony Biosciences CFO Sells Shares Amid Strong Earnings
Feb 01 2026
NASDAQ.COM
Harmony Biosciences: Future Prospects and Challenges Ahead
Jan 28 2026
Fool
Harmony Biosciences Expands Wakix Patent Life with New Treatments
Jan 28 2026
NASDAQ.COM
Harmony Biosciences: Financial Success Amidst Challenges
Jan 27 2026
Fool
Show More News
